Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study - Concepedia

Concepedia

Publication | Closed Access

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study

1.3K

Citations

10

References

2008

Year

David M. Brown, Mark Michels, Peter K. Kaiser, Jeffrey S. Heier, Judy P. Sy, Tsontcho Ianchulev

Ocular DiseaseOphthalmologyTwo-year ResultsPhotodynamic TherapyAge-related DiseasesGlaucomaMedicineAnchor Study

References

	Year	Citations

Page 1